| PACKAGING TYPE: | 6x10 Blister (06 Strip In 1 Box) |
| COMPOSITION: | Each Film Coated Tablet Contains : Empagliflozin - 12.5mg , Metformin Hydrochloride Ip - 500mg. |
| FORMULATION: | Tablet |
| Description: | EMPACON MET 12.5/500 Tablet is a combination of Empagliflozin 12.5mg (SGLT2 inhibitor) and Metformin 500mg (biguanide), used in the management of type 2 diabetes mellitus. Empagliflozin lowers blood glucose by promoting urinary glucose excretion, while Metformin reduces hepatic glucose production and enhances insulin sensitivity. This balanced-dose combination offers effective glycemic control and is suitable for patients requiring moderate intensification of therapy. |
| Side Effects: | Common side effects may include: Nausea Diarrhea Increased urination Abdominal discomfort Loss of appetite Serious side effects: Lactic acidosis (rare but serious, Metformin-related) Ketoacidosis (Empagliflozin-related) Kidney function impairment Dehydration Vitamin B12 deficiency (long-term use) |
| How to Use: | Take EMPACON MET 12.5/500 Tablet as prescribed by a healthcare professional Usually taken once or twice daily with meals Swallow the tablet whole with water Do not skip meals while taking this medication Maintain adequate hydration |
| Precaution: | Monitor kidney function regularly Avoid excessive alcohol intake Use cautiously in patients with liver or kidney disorders Inform your doctor about other antidiabetic medications Not recommended in type 1 diabetes Avoid use during pregnancy or breastfeeding without medical advice |
| Product Benefits: | Dual-action mechanism for effective blood sugar control Improves insulin sensitivity and glucose metabolism Helps reduce HbA1c levels Supports weight management Provides cardiovascular and metabolic benefits Suitable for patients needing moderate dos |
Frequently Asked Questions
It is used to manage blood sugar levels in type 2 diabetes with dual-action therapy.
It is suitable for patients requiring moderate glucose control with combination therapy.
It has a low risk when used alone, but risk may increase with other diabetes medications.

















